Oral small molecule GLP-1R agonist PF-06882961 robustly reduces plasma glucose and body weight after 28 days in adults with t2dm

Category Primary study
JournalDiabetes
Year 2020
This article has no abstract
Epistemonikos ID: e4ec8053d1b9e9dcfb431a604efe798c23feaf64
First added on: Feb 12, 2025